Insights

Innovative Cancer Research CSI-Cancer at USC Michelson Center specializes in translating complex cancer dynamics through high-content single cell data integration, offering opportunities for advanced bioinformatics and data analytics solutions tailored to research institutions focused on mechanistic cancer understanding.

Technology Stack Integration The company's use of advanced technologies such as Oracle Cloud, GitLab, and GraphQL indicates a strong reliance on cutting-edge data management and visualization tools, opening avenues to provide cloud infrastructure, big data processing, and software development services.

Academic-Industry Collaboration Recent partnerships with organizations like OpenAI and Bizora suggest a growing engagement with AI and data-driven solutions, presenting opportunities to offer AI deployment, machine learning tools, and collaborative research platforms to enhance cancer modeling and predictive analytics.

Funding and Expansion Needs Despite a modest revenue base, USC Michelson Center's recent layoffs and funding constraints highlight a potential market for cost-effective research support services, grant management solutions, and technological upgrades to bolster research capabilities without significant overhead.

Market Positioning As part of a competitive landscape with larger cancer centers and research institutes, the company’s focus on spatial and temporal cancer dynamics provides a niche opportunity to differentiate with specialized software, visualization tools, and data integration platforms aimed at academic and healthcare sectors.

Similar companies to CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Tech Stack

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses 8 technology products and services including OpenGL, Oracle Cloud, 3M 360 Encompass, and more. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack below.

  • OpenGL
    Audio, Video, Graphics
  • Oracle Cloud
    Data Management Platforms
  • 3M 360 Encompass
    Electronic Health Records
  • EMC Isilon
    Enterprise Data Storage
  • PatientKeeper
    Health Platform
  • GitLab
    Issue Trackers
  • GraphQL
    Programming Languages
  • Linux
    Programming Languages

Media & News

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's Email Address Formats

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses at least 2 format(s):
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Email FormatsExamplePercentage
First.Last@usc.eduJohn.Doe@usc.edu
60%
FLast@usc.eduJDoe@usc.edu
28%
Last@usc.eduDoe@usc.edu
7%
FirstL@usc.eduJohnD@usc.edu
5%

Frequently Asked Questions

Where is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's headquarters located?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's main headquarters is located at 1002 Childs Way Michelson Hall Los Angeles, California United States. The company has employees across 2 continents, including North AmericaEurope.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website and social media links?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website is kuhn.usc.edu and has social profiles on LinkedIn.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer have currently?

Minus sign iconPlus sign icon
As of March 2026, CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer has approximately 31 employees across 2 continents, including North AmericaEurope. Key team members include Director: D. T.Front Desk Assistant: R. C.Undergraduate Researcher: A. L.. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's employee directory with LeadIQ.

What industry does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer belong to?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer operates in the Research Services industry.

What technology does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer use?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack includes OpenGLOracle Cloud3M 360 EncompassEMC IsilonPatientKeeperGitLabGraphQLLinux.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format typically follows the pattern of First.Last@usc.edu. Find more CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer email formats with LeadIQ.

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

Research ServicesCalifornia, United States11-50 Employees

USC Michelson Center CSI-Cancer is aimed at integrating patient, model system, and high-content single cell data to translate clinically observed correlations into a mechanistic understanding of the physical and biological underpinnings of cancer dynamics. The organizing framework of the physical dynamics of cancer at the lab will focus on the spatial distributions and temporal evolution of the disease at the cellular, human, and population scale.

Section iconCompany Overview

Headquarters
1002 Childs Way Michelson Hall Los Angeles, California United States
NAICS Code
5417 - Scientific Research and Development Services
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.